Abstract
Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease leading to continuous mucosal inflammation in the rectum extending proximally towards the colon. Chronic and/or recurrent UC is one of the critical predisposing mediators of the oncogenesis of human colorectal carcinoma (CRC). Perturbations of the differential expression of the UC-critical genes exert an intense impact on the neoplastic transformation of the affected tissue(s). Herein, a comprehensive exploration of the UC-critical genes from the transcriptomic profiles of UC patients was conducted to study the differential expression, functional enrichment, genomic alterations, signal transduction pathways, and immune infiltration level encountered by these genes concerning the oncogenesis of CRC. The study reveals that WFDC2, TTLL12, THRA, and EPHB3 play crucial roles as UC-CRC critical genes and are positively correlated with the molecular transformation of UC to CRC. Taken together, these genes can be used as potential biomarkers and therapeutic targets for combating UC-induced human CRC.
Publisher
Public Library of Science (PLoS)
Reference61 articles.
1. The global burden of IBD: from 2015 to 2025.;GG Kaplan;Nat Rev Gastroenterol Hepatol,2015
2. Ulcerative colitis.;T Kobayashi;Nat Rev Dis Prim,2020
3. An improved method for experimental induction of Ulcerative colitis in Sprague Dawley rats.;R Patra;MethodsX,2023
4. Crohn’s disease.;J Torres;Lancet,2017
5. Global burden of irritable bowel syndrome: trends, predictions and risk factors.;CJ Black;Nat Rev Gastroenterol Hepatol,2020